Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.15 USD | -2.83% | +0.98% | -33.89% |
Jun. 05 | Transcript : Syros Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.89% | 138M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Oppenheimer Adjusts Syros Pharmaceuticals Price Target to $13 From $15, Maintains Outperform Rating